Bunkerhill Abdominal Aortic Quantification (AAQ) vs HeartFlow Analysis

Bunkerhill AAQ, through its Carebricks platform, emphasizes a 'no-code' approach to building and deploying AI agents, streamlining and automating clinical workflows with seamless EHR integration. This focus on reducing clinician workload and enabling rapid integration and collaboration for diverse needs suggests a higher degree of user empowerment and adaptability. HeartFlow focuses on a non-invasive diagnostic process with minimal patient effort, but Bunkerhill's platform offers more explicit tools for workflow customization and efficiency for healthcare teams.

HeartFlow Analysis has a more extensive and long-standing body of clinical evidence, backed by over 600 peer-reviewed publications and validated in over 200 studies, demonstrating significant impact on reducing unnecessary invasive procedures and guiding CAD treatment. While Bunkerhill AAQ offers innovative 'first FDA-cleared' solutions for opportunistic screening in its domain, HeartFlow's established and widely recognized clinical utility, including its impact on patient management and outcomes, gives it an edge.

HeartFlow Analysis offers a clear fee-for-service model with established Category I CPT codes and widespread coverage by Medicare and most U.S. commercial payers, providing transparent and predictable reimbursement for providers. HeartFlow also offers dedicated billing and reimbursement support. While Bunkerhill Health has recently secured a CMS reimbursement pathway for some of its cardiovascular analyses, HeartFlow's mature and broadly recognized reimbursement infrastructure offers greater financial predictability and proven value.

Both tools demonstrate strong enterprise readiness with cloud deployment, HIPAA compliance, BAA, and FDA clearance. However, Bunkerhill's Carebricks platform is designed as a flexible 'system of action' that enables health systems to build and deploy custom, enterprise-scale AI agents that integrate deeply with EHRs and automate end-to-end workflows across various specialties. This customizable and scalable approach for diverse clinical and operational tasks provides a more comprehensive enterprise solution.

While HeartFlow pioneered FFRct and CFD for non-invasive CAD diagnosis, Bunkerhill AAQ explicitly highlights its use of 'generative AI' and 'large language and foundation models' for clinical reasoning and action. Bunkerhill has also achieved multiple 'first FDA-cleared' statuses for opportunistic screening applications, indicating a more recent and advanced application of AI technologies to broader and more flexible clinical workflows.

HeartFlow provides a comprehensive support system, including dedicated specialists for billing, technical integration, and educational resources through 'HeartFlow University' offering CEUs. They also offer robust, multi-language online documentation and context-sensitive help. Bunkerhill's public information on specific support channels and documentation is not as detailed or readily available.